These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35017302)

  • 1. Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis.
    Michaels WE; Pena-Rasgado C; Kotaria R; Bridges RJ; Hastings ML
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017302
    [No Abstract]   [Full Text] [Related]  

  • 2. Exon-skipping antisense oligonucleotides for cystic fibrosis therapy.
    Kim YJ; Sivetz N; Layne J; Voss DM; Yang L; Zhang Q; Krainer AR
    Proc Natl Acad Sci U S A; 2022 Jan; 119(3):. PubMed ID: 35017301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation.
    Oren YS; Avizur-Barchad O; Ozeri-Galai E; Elgrabli R; Schirelman MR; Blinder T; Stampfer CD; Ordan M; Laselva O; Cohen-Cymberknoh M; Kerem E; Bear CE; Kerem B
    J Cyst Fibros; 2022 Jul; 21(4):630-636. PubMed ID: 34972649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy.
    Kim YJ; Nomakuchi T; Papaleonidopoulou F; Yang L; Zhang Q; Krainer AR
    Nat Commun; 2022 May; 13(1):2978. PubMed ID: 35624092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells.
    Michaels WE; Bridges RJ; Hastings ML
    Nucleic Acids Res; 2020 Jul; 48(13):7454-7467. PubMed ID: 32520327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsense-mediated RNA Decay Pathway Inhibition Restores Expression and Function of W1282X CFTR.
    Keenan MM; Huang L; Jordan NJ; Wong E; Cheng Y; Valley HC; Mahiou J; Liang F; Bihler H; Mense M; Guo S; Monia BP
    Am J Respir Cell Mol Biol; 2019 Sep; 61(3):290-300. PubMed ID: 30836009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
    Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
    Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives.
    Kim YJ; Krainer AR
    Mol Cells; 2023 Jan; 46(1):10-20. PubMed ID: 36697233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppression of premature termination codons and the repair of splicing mutations in CFTR.
    Oren YS; Pranke IM; Kerem B; Sermet-Gaudelus I
    Curr Opin Pharmacol; 2017 Jun; 34():125-131. PubMed ID: 29128743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
    Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
    Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations.
    Mutyam V; Sharma J; Li Y; Peng N; Chen J; Tang LP; Falk Libby E; Singh AK; Conrath K; Rowe SM
    Am J Respir Cell Mol Biol; 2021 May; 64(5):604-616. PubMed ID: 33616476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model.
    Bednarski C; Tomczak K; Vom Hövel B; Weber WM; Cathomen T
    PLoS One; 2016; 11(8):e0161072. PubMed ID: 27526025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional rescue of c.3846G>A (W1282X) in patient-derived nasal cultures achieved by inhibition of nonsense mediated decay and protein modulators with complementary mechanisms of action.
    Laselva O; Eckford PD; Bartlett C; Ouyang H; Gunawardena TN; Gonska T; Moraes TJ; Bear CE
    J Cyst Fibros; 2020 Sep; 19(5):717-727. PubMed ID: 31831337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides.
    Friedman KJ; Kole J; Cohn JA; Knowles MR; Silverman LM; Kole R
    J Biol Chem; 1999 Dec; 274(51):36193-9. PubMed ID: 10593905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of W1282X CFTR activity by enhanced expression.
    Rowe SM; Varga K; Rab A; Bebok Z; Byram K; Li Y; Sorscher EJ; Clancy JP
    Am J Respir Cell Mol Biol; 2007 Sep; 37(3):347-56. PubMed ID: 17541014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon 9 of the CFTR gene: splice site haplotypes and cystic fibrosis mutations.
    Dörk T; Fislage R; Neumann T; Wulf B; Tümmler B
    Hum Genet; 1994 Jan; 93(1):67-73. PubMed ID: 7505767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.
    Liu X; Luo M; Zhang LN; Yan Z; Zak R; Ding W; Mansfield SG; Mitchell LG; Engelhardt JF
    Hum Gene Ther; 2005 Sep; 16(9):1116-23. PubMed ID: 16149910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis.
    Will K; Dörk T; Stuhrmann M; Meitinger T; Bertele-Harms R; Tümmler B; Schmidtke J
    J Clin Invest; 1994 Apr; 93(4):1852-9. PubMed ID: 7512993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.
    Chu CS; Trapnell BC; Curristin S; Cutting GR; Crystal RG
    Nat Genet; 1993 Feb; 3(2):151-6. PubMed ID: 7684646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis.
    Chu CS; Trapnell BC; Curristin SM; Cutting GR; Crystal RG
    J Clin Invest; 1992 Sep; 90(3):785-90. PubMed ID: 1381723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.